Baxter Healthcare Corp.’s injectable drug for treating severely low blood pressure doesn’t literally infringe five Nevakar ...

Baxter’s stock price fell to $36.42. Shareholders have lost 7.3% of their capital, which is disappointing considering the S&P ...

D EERFIELD, IL – Baxter International Inc. (NYSE:BAX), a global leader in medical products with a market capitalization of $16.65 billion and annual revenue of $15.06 billion, announced today ...

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion ...

Feb 20 (Reuters) - Baxter International (BAX.N), opens new tab on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's ...

Carla Baxter started her store, Baxter Beauty Supply, in November 2023 and will soon be moving the business to a new Redding ...

caregivers and healthcare providers rely on Baxter's leading portfolio of diagnostic, critical care, nutrition, hospital and surgical products used across patient homes, hospitals, physician ...

offset by select product/market exits. Guidance: Baxter expects 2025 adjusted EPS of $2.45-$2.55 versus consensus of $2.47, with sales growth of 5%-6% on a reported basis and 4%-5% on an organic ...

Baxter's Voalte platform is a unified digital care communications solution. The Linq device integrates with existing products in Baxter's connected care portfolio including Voalte mobile ...

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.